ofloxacin - Profile
✉ Email this page to a colleague
What are the generic drug sources for ofloxacin and what is the scope of patent protection?
Ofloxacin
is the generic ingredient in six branded drugs marketed by Ortho Mcneil Pharm, Bedford, Allergan, Altaire Pharms Inc, Alvogen, Amneal, Apotex Inc, Bausch And Lomb, Caplin, Epic Pharma Llc, Fdc Ltd, Mankind Pharma, Micro Labs, Sandoz, Sentiss, Somerset, Daiichi, Bausch And Lomb Inc, Hikma, Somerset Theraps Llc, Janssen Pharms, Cadila Pharms Ltd, Chartwell Rx, Dr Reddys Labs Ltd, Ranbaxy Labs Ltd, and Teva, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.There is one tentative approval for this compound.
Summary for ofloxacin
| US Patents: | 0 |
| Tradenames: | 6 |
| Applicants: | 26 |
| NDAs: | 34 |
Generic filers with tentative approvals for OFLOXACIN
| Applicant | Application No. | Strength | Dosage Form |
| ⤷ Start Trial | ⤷ Start Trial | 400MG | TABLET;ORAL |
| ⤷ Start Trial | ⤷ Start Trial | 300MG | TABLET;ORAL |
| ⤷ Start Trial | ⤷ Start Trial | 200MG | TABLET;ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
US Patents and Regulatory Information for ofloxacin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Pharm | FLOXIN | ofloxacin | INJECTABLE;INJECTION | 020087-002 | Mar 31, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ortho Mcneil Pharm | FLOXIN | ofloxacin | INJECTABLE;INJECTION | 020087-003 | Mar 31, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ortho Mcneil Pharm | FLOXIN IN DEXTROSE 5% | ofloxacin | INJECTABLE;INJECTION | 020087-001 | Mar 31, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ortho Mcneil Pharm | FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ofloxacin | INJECTABLE;INJECTION | 020087-004 | Mar 31, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ofloxacin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen Pharms | FLOXIN | ofloxacin | TABLET;ORAL | 019735-003 | Dec 28, 1990 | 4,382,892 | ⤷ Start Trial |
| Ortho Mcneil Pharm | FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ofloxacin | INJECTABLE;INJECTION | 020087-005 | Mar 31, 1992 | 4,382,892 | ⤷ Start Trial |
| Ortho Mcneil Pharm | FLOXIN | ofloxacin | INJECTABLE;INJECTION | 020087-002 | Mar 31, 1992 | 4,382,892 | ⤷ Start Trial |
| Ortho Mcneil Pharm | FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ofloxacin | INJECTABLE;INJECTION | 020087-004 | Mar 31, 1992 | 4,382,892 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
